We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
+$1.68B
(+5.7%)
Cap. Flow
+$21M
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$39M |
| 2 |
Hewlett Packard
HPE
|
+$35.3M |
| 3 |
Synchrony
SYF
|
+$29.5M |
| 4 |
Comcast
CMCSA
|
+$25.4M |
| 5 |
Illumina
ILMN
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CB
CHUBB CORPORATION
CB
|
+$43M |
| 2 |
HP
HPQ
|
+$38.8M |
| 3 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$25.8M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$22.9M |
| 5 |
ALTR
Altera Corp
ALTR
|
+$21.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.31% |
| 2 | Healthcare | 14.62% |
| 3 | Technology | 14.1% |
| 4 | Industrials | 10.66% |
| 5 | Consumer Discretionary | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$167B
| $209M | 0.67% |
2,067,512
-15,694
| -0.8% | -$1.63M |
|
|
27
Comcast
CMCSA
$85.8B
| $200M | 0.64% |
7,085,290
+844,642
| +14% | +$25.4M |
|
28
Cisco
CSCO
$456B
| $196M | 0.63% |
7,203,078
+477
| +0% | +$13.2K |
|
29
Merck
MRK
$326B
| $194M | 0.63% |
3,856,998
-16,517
| -0.4% | -$833K |
|
30
IBM
IBM
$214B
| $181M | 0.58% |
1,372,019
-12,117
| -0.9% | -$1.63M |
|
31
Amgen
AMGN
$212B
| $178M | 0.57% |
1,099,267
-14,099
| -1% | -$2.22M |
|
32
Philip Morris
PM
$312B
| $172M | 0.55% |
1,960,765
-17,827
| -0.9% | -$1.55M |
|
33
UnitedHealth
UNH
$389B
| $171M | 0.55% |
1,455,047
-4,135
| -0.3% | -$483K |
|
34
Oracle
ORCL
$346B
| $170M | 0.55% |
4,653,147
-23,739
| -0.5% | -$907K |
|
35
McDonald's
MCD
$194B
| $167M | 0.54% |
1,411,958
-3,322
| -0.2% | -$371K |
|
36
CVS Health
CVS
$140B
| $160M | 0.52% |
1,639,939
-9,787
| -0.6% | -$959K |
|
37
Bristol-Myers Squibb
BMY
$130B
| $150M | 0.48% |
2,186,591
-14,078
| -0.6% | -$930K |
|
|
AGN
38
DELISTED
Allergan plc
AGN
| $149M | 0.48% |
476,114
+828
| +0.2% | +$247K |
|
39
3M
MMM
$94.1B
| $148M | 0.48% |
1,177,760
+5,283
| +0.5% | +$679K |
|
40
Medtronic
MDT
$111B
| $140M | 0.45% |
1,818,206
+2,980
| +0.2% | +$224K |
|
41
Mastercard
MA
$497B
| $139M | 0.45% |
1,425,957
-5,062
| -0.4% | -$496K |
|
42
Altria Group
MO
$125B
| $136M | 0.44% |
2,342,184
-29,986
| -1% | -$1.74M |
|
43
Walmart Inc
WMT
$900B
| $134M | 0.43% |
6,575,709
-100,317
| -2% | -$2.01M |
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $133M | 0.43% |
1,112,532
-6,767
| -0.6% | -$783K |
|
45
Boeing
BA
$175B
| $132M | 0.42% |
911,956
-7,595
| -0.8% | -$1.09M |
|
46
Starbucks
SBUX
$118B
| $128M | 0.41% |
2,124,406
+13,665
| +0.6% | +$832K |
|
47
AbbVie
ABBV
$465B
| $126M | 0.41% |
2,128,538
-270,650
| -11% | -$15.6M |
|
48
SLB Ltd
SLB
$74.2B
| $122M | 0.39% |
1,753,202
+51,724
| +3% | +$3.87M |
|
49
Nike
NKE
$63.9B
| $122M | 0.39% |
1,950,136
-23,802
| -1% | -$1.54M |
|
50
Qualcomm
QCOM
$172B
| $112M | 0.36% |
2,249,052
-58,050
| -3% | -$3.1M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2015 Portfolio in Review
As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
- RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
- RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
- RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
- RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
- RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
- RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
- RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.
Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.